![Gabriel Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriel Brooks
Hoofd Techniek/Wetenschap/O&O bij
SOLID BIOSCIENCES INC.
Vermogen: 857 084 $ op 31-08-2026
Profiel
Gabriel Brooks is Chief Medical Officer at Solid Biosciences, Inc. since 2023.
Formerly, Dr. Brooks was Vice President-Research & Development at 4D Molecular Therapeutics, Inc. from 2018 to 2020.
Education includes undergraduate studies at Carnegie Mellon University, a doctorate from Cornell University, and graduate studies at the University of California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 89.466 ( 0,08% ) | 857 084 $ | 31-08-2026 |
Actieve functies van Gabriel Brooks
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Hoofd Techniek/Wetenschap/O&O | 02-10-2023 |
Eerdere bekende functies van Gabriel Brooks
| Bedrijven | Functie | Einde |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2020 |
Opleiding van Gabriel Brooks
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
